Home›Stock Screener›Astonea Labs›Quarterly Results

Astonea Labs Quarterly Results

Latest Quarter Net Profit
₹5 Cr
QMarch 2026
Quarterly Results

Astonea Labs quarterly results. In 2026, Astonea Labs (ASTONEALAB) reported revenue ₹0 Cr and net profit ₹0 Cr. Check ASTONEALAB market value to track the company's total market size over time.

ASTONEALAB Quarterly Results — Revenue, Profit & EPS Highlights

Astonea Labs latest quarter revenue, net profit, EPS and QoQ/YoY growth rates. For annual financials, live price and key ratios, visit Astonea Labs share price screener.

  • Revenue of ₹148 Cr in March 2026 (+0.0% vs March 2026, +51.0% vs March 2025)
  • Net Profit of ₹5 Cr in March 2026 (+0.0% vs March 2026, +0.0% vs March 2025)
  • EBITDA of ₹14 Cr in March 2026 (+0.0% vs March 2026)
  • Operating Margin of 9.0% in March 2026 (+0.0pp vs March 2026)
  • Earnings Per Share of ₹4.49 in March 2026 (+0.0% vs March 2026)

Astonea Labs Quarterly Results — Revenue, EBITDA, Net Profit & EPS

ASTONEALAB quarterly revenue, expenses, EBITDA, net profit, EPS and operating margin with QoQ and YoY comparison.

Metric 2026 March 2026 March 2025 QoQ YoY
Revenue (₹ Cr) 0 148 98 - -
Net Profit (₹ Cr) 0 5 5 - -
EBITDA (₹ Cr) 0 14 15 - -
EPS (₹) 0.00 4.49 6.94 - -
Operating Margin (%) 0.0% 9.0% 16.0% - -

ASTONEALAB Share Price Trend — 1-Year Movement Across Quarterly Results

Astonea Labs 1-year share price in ₹ overlaid with quarterly earnings dates — NSE/BSE closing prices. Review ASTONEALAB P/E comparison to evaluate earnings-based valuation against sector peers.

Profitability Ratios

Profit Margin 3.4%
EBITDA Margin 9.5%
Operating Margin 9.0%
ROE (Annual) 8.8%

Balance Sheet Highlights

Total Assets ₹146 Cr
Total Equity ₹57 Cr
Current Assets ₹98 Cr
Current Liabilities ₹21 Cr

Cash Flow Analysis

Operating Cash Flow ₹-14 Cr
Investing Cash Flow ₹-20 Cr
Financing Cash Flow ₹34 Cr
Net Cash Flow ₹0 Cr

Revenue Trend (₹ Cr)

March 2025 98
March 2026 148
2026 0

Net Profit Trend (₹ Cr)

March 2025 5
March 2026 5
2026 0

Operating Margin Trend (%)

March 2025 16.0%
March 2026 9.0%
2026 0.0%

ASTONEALAB vs Healthcare Peers — Quarterly Revenue, Profit & Market Cap

Astonea Labs latest quarter revenue and net profit vs Healthcare competitors — market cap, price and earnings comparison.

Company Latest Quarter Market Cap (₹ Cr) Price (₹) Revenue (₹ Cr) Net Profit (₹ Cr) Rev QoQ % Rev YoY % Profit Margin % P/E Ratio
Sun Pharmaceutical
Mar 2026 		₹432,120.23 Cr 1779.7 15,018 2,710 -5.6% - 18.0% 157.5
Divis Laboratories
Mar 2026 		₹253,522.49 Cr 9196.0 2,986 751 -5.0% - 25.2% 324.8
Torrent Pharmaceuti…
Mar 2026 		₹188,719.51 Cr 4772.0 4,111 364 +27.7% +42.2% 8.9% 414.6
Zydus Life Science
Mar 2026 		₹113,615.69 Cr 1139.0 7,569 1,341 -4.3% - 17.7% 90.0
Cipla
Mar 2026 		₹108,576.18 Cr 1335.5 6,612 543 -9.3% - 8.2% 194.4
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data

QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores